NCT02095808View on ClinicalTrials.gov

Metabolic Biomarkers in Thoracic Cancers

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 20, 2013

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Lung Cancer
Interventions
PROCEDURE

Imaging Biomarkers

Want to see if using 13C-glucose helps in detecting cancer and deciding on a treatment plan.

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02095808 - Metabolic Biomarkers in Thoracic Cancers | Biotech Hunter | Biotech Hunter